STOCK TITAN

Cadre Holdings, Inc. SEC Filings

CDRE NYSE

Welcome to our dedicated page for Cadre Holdings SEC filings (Ticker: CDRE), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Cadre Holdings's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.

Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Cadre Holdings's regulatory disclosures and financial reporting.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-15.86%
Tags
current report
-
Rhea-AI Summary

Cadre Holdings, Inc. (CDRE) Form 4 filing: CEO, Chairman and 10% owner Warren B. Kanders reported the sale of 25,000 common shares on 06/23/2025. The transaction, coded “S”, was executed at a weighted-average price of $32.78 per share through the insider-controlled entity Kanders SAF, LLC.

Following the disposition, Kanders’ reported beneficial ownership stands at 10,216,192 shares indirectly via Kanders SAF, LLC, 45,584 shares held directly, 1,305,650 shares held in his Roth IRA, and 23,450 shares held in his spouse’s Roth IRA, for an aggregate of approximately 11.59 million shares. The sale thus represents roughly 0.22 % of his total reported holdings, leaving his ownership well above the 10 % threshold.

No derivative securities were reported, and the footnotes confirm that the reported price is weighted across multiple trades ranging $32.67-$32.96. Kanders remains the sole manager of Kanders SAF, LLC and disclaims beneficial ownership beyond his pecuniary interest.

Key takeaway: The filing shows a modest insider sale in dollar terms (~$0.8 million) relative to Kanders’ large strategic stake, with no indication of broader changes in ownership structure or corporate strategy.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Cadre Holdings (CDRE) – Form 4 filed 06/23/2025. CEO, Chairman and 10% owner Warren B. Kanders disclosed two open-market sales executed through his controlled entity, Kanders SAF, LLC.

  • 06/18/2025: 50,000 common shares sold at a weighted-average price of $33.95.
  • 06/20/2025: 50,000 common shares sold at a weighted-average price of $33.01.

The combined 100,000-share disposal generated roughly $3.3 million in gross proceeds. Following the transactions, Kanders SAF’s holding declined to 10,241,192 shares. Additional positions remain unchanged: 45,584 shares held directly, 1,305,650 in Warren B. Kanders’ Roth IRA, and 23,450 in his spouse’s Roth IRA.

No derivative activity was reported, and the filing does not indicate the sales were made under a Rule 10b5-1 plan. While the sale size is modest relative to Kanders’ total ownership, it represents the first reported share reduction in 2025 and may be monitored by investors for sentiment signals.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider

FAQ

How many Cadre Holdings (CDRE) SEC filings are available on StockTitan?

StockTitan tracks 73 SEC filings for Cadre Holdings (CDRE), including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and Form 4 insider trading disclosures. Each filing includes AI-generated summaries, impact scoring, and sentiment analysis.

When was the most recent SEC filing for Cadre Holdings (CDRE)?

The most recent SEC filing for Cadre Holdings (CDRE) was filed on August 5, 2025.